SSG
RNLX

Summit Securities Group’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Summit Securities Group’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,809
Closed – – 973
2024
Q3 		$0 Hold
1,809
– – ﹤0.01% 935
2024
Q2 		$0 Hold
1,809
– – ﹤0.01% 843
2024
Q1 		$2K Hold
1,809
– – ﹤0.01% 392
2023
Q4 		$1K Hold
1,809
– – ﹤0.01% 639
2023
Q3 		$3K Hold
1,809
– – ﹤0.01% 505
2023
Q2 		$5K Hold
1,809
– – ﹤0.01% 820
2023
Q1 		$4K Buy
+1,809
New +$5.02K ﹤0.01% 725

Other funds holding RNLX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $694M AUM 16.84% 1-Year Est. Return

Summit Securities Group's RNLX Position: Q4 2024 in Review

Summit Securities Group sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 1,809 shares.

Summit Securities Group first reported a position in RNLX in Q1 2023 and held it in 7 quarters. The position peaked at $5K in Q2 2023. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • Summit Securities Group reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Summit Securities Group sold 1,809 Renalytix plc American Depositary Shares shares in Q4 2024.
  • Summit Securities Group first reported a position in Renalytix plc American Depositary Shares in Q1 2023 and held it in 7 quarters.
  • Summit Securities Group's Renalytix plc American Depositary Shares position peaked at $5K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Summit Securities Group's 13F filing for Q4 2024, filed 12 Feb 2025.